Companies House · 00302461

TEVA UK LIMITED

UK registered company, private limited company, incorporated 1 Jul 1935.

Active
50
Public contracts
1
Spend payments
£312
Total spend

TEVA UK LIMITED is a UK company registered at Companies House under number 00302461. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
00302461
Status
Active
Company type
Private Limited Company
Incorporated
1 Jul 1935
Country of origin
United Kingdom
Registered office
RIDINGS POINT, CASTLEFORD, ENGLAND, WF10 5HX, ENGLAND
Nature of business (SIC)
21200 - Manufacture of pharmaceutical preparations
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to TEVA UK LIMITED.

ProcurementBuyerAwardedValue
NHS National Framework for Generics HousekeepingNHS England
Transitional Drugs 2Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England25 Nov 2025£25.9m
NHS National Framework for Denosumab Injection commencing 1st January 2026NHS England North East & Yorkshire29 Sept 2025£37.7m
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025NHS England North East & Yorkshire30 Jul 2025£688.8m
NHS National Framework for Transition products (Axitinib and Eltrombopag)NHS England15 Jul 2025£52.4m
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS National Framework - Generics Housekeeping/Supply Chain Resilience ProductsNHS England15 Apr 2025£11.7m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
NHS National Framework for Transition products commencing 1 October 2024NHS England29 Sept 2024£16.2m
NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024NHS England24 Jul 2024£416.8m
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS National Framework for Transition products commencing 1 May 2024NHS ENGLAND15 Apr 2024£7.6m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England4 Mar 2024£1
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
NHS National Generics Pharmaceuticals Transition 2023_1NHS england4 May 2023£57.6m
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England23 Apr 2023£304.5m
NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone InjectionNHS england27 Mar 2023£27m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS National Pharmaceuticals Transition 2022_2NHS England1 Nov 2022£35.7m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
NHS Framework Agreement for the supply of Medical Retinal Vascular TreatmentsNHS England25 May 2022£350k
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
National Procurement for HIV and Preventative TreatmentsNHSE&I1 Feb 2022£230m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Pharmaceuticals Transition 2021_3NHS England21 Oct 2021£26m
NHS Framework Agreement for Branded Medicines - NationalNHS England26 Sept 2021£95.2m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS National Pharmaceuticals - Everolimus and terminated agreement productsNHS England7 Jun 2021£4.5m

Supplier identities

How this company appears as a supplier across the data.

Recent transparency payments

1 payment recorded, totalling £312.

PayerDescriptionDateAmount
department-for-business-energy-and-industrial-strategyRecoveries Account - Other Payables31 Jan 2017£312

FAQs about TEVA UK LIMITED

Is TEVA UK LIMITED an active company?

TEVA UK LIMITED (company number 00302461) is recorded as "Active", incorporated on 1 Jul 1935.

What does TEVA UK LIMITED do?

Its Companies House nature-of-business (SIC) is: 21200 - Manufacture of pharmaceutical preparations.

Has TEVA UK LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

How much public money has TEVA UK LIMITED received?

1 transparency-spend payment totalling £312 is recorded against TEVA UK LIMITED.

Where is TEVA UK LIMITED based?

Its registered office is RIDINGS POINT, CASTLEFORD, ENGLAND, WF10 5HX, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable